Entry of mouse hepatitis virus into cells by endosomal and nonendosomal pathways

Virology

Volumn 233, Issue 1, 1997, Pages 1-8

  Nash, Therese C ^a   Buchmeier, Michael J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE K;

ACIDIFICATION; ANIMAL CELL; ARTICLE; CELL FUSION; CELL LYSATE; CELL MEMBRANE; CELL SURFACE; ELECTRON MICROSCOPY; ENDOCYTOSIS; ENDOSOME; INTERNALIZATION; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; SYNCYTIUM; VIRUS ADSORPTION; VIRUS INFECTION;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; MURINE HEPATITIS VIRUS STRAIN 4;

EID: 0030754578     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8609     Document Type: Article

References (40)

1. Asanaka M., Lai M. M. C. Cell fusion studies identified multiple cellular factors involved in mouse hepatitis virus entry. Virology. 197:1993;732-741.
2. Borrow P., Oldstone M. B. A. Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology. 198:1994;1-9.
3. Bowman E. J., Siebers A., Altendorf K. Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA. 85:1988;7972-7976.
4. M. J. Buchmeier, T. M. Gallagher, T. C. Nash, 1997, Novel fusion mutations in the coronavirus spike protein map to cleavage products S1 and S2 and mediate their non-covalent interactions.
5. David-Ferreira J. F., Manaker R. A. An electron microscope study of the development of a mouse hepatitis virus in tissue culture cells. J. Cell Biol. 24:1965;57-78.
6. de Groot R. J., Luytjes W., Horzinek M. C., van der Zeijst B. A. M., Spaan W. J. M., Lenstra J. A. Evidence of a coiled-coil structure in the spike proteins of coronaviruses. J. Mol. Biol. 196:1987;963-966.
7. Delmas B., Laude H. Assembly of coronavirus spike protein into trimers and its role in epitope expression. J. Virol. 64:1990;5367-5375.
8. Flintoff W. F., Van Dinter S. Several rat cell lines share a common defect in their ability to internalize murine coronaviruses efficiently. J. Gen. Virol. 70:1989;1713-1724.
9. Frana M. F., Behnke J. N., Sturman L. S., Holmes K. V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Host-dependent differences in proteolytic cleavage and cell fusion. J. Virol. 56:1985;912-920.
10. Gallagher T. M., Escarmis C., Buchmeier M. J. Alteration of the pH dependence of coronavirus-induced cell fusion: Effect of mutation in the spike glycoprotein. J. Virol. 65:1991;1916-1928.
11. Gallagher T. M., Buchmeier M. J., Perlman S. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology. 191:1992;517-522.
12. Gombold J. L., Hingley S. T., Weiss S. R. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:1993;4504-4512.
13. Haspel M. V., Lampert P. W., Oldstone M. B. A. Temperature sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc. Natl. Acad. Sci. USA. 75:1978;4033-4036.
14. Helenius A., Kartenbeck J., Simons K., Fries E. On the entry of Semliki Forest virus into cells. J. Cell. Biol. 84:1980;404-420.
15. Helenius A., Marsh M., White J. Inhibition of Semliki Forest virus penetration by lysosomotropic weak bases. J. Gen. Virol. 58:1982;47-61.
16. Hirano N., Goto N., Makino S., Fujiwara K. Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. Jpn. J. Exp. Med. 48:1978;71-75.
17. Holmes K. V., Lai M. M. C. Coronaviridae: The viruses and their replication. Virology. 1996;Lippincott-Raven, New York. p. 1075-.
18. Kooi C., Cervin M., Anderson R. Differentiation of acid-pH-dependent and -nondependent entry pathways for mouse hepatitis virus. Virology. 180:1991;108-119.
19. Krzystyniak K., Dupuy J. M. Entry of mouse hepatitis virus 3 into cells. J. Gen. Virol. 65:1984;227-231.
20. Kubo H., Yamada Y. K., Taguchi F. Localization of the neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68:1994;5403-5410.
21. Mallucci L. Effect of chloroquine on lysosomes and on growth of mouse hepatitis virus (MHV-3). Virology. 28:1966;355-362.
22. Marsh M., Wellsteed J., Kern H., Hars E., Helenius A. Monensin inhibits Semliki Forest virus penetration into culture cells. Proc. Natl. Acad. Sci. USA. 79:1982;5297-5301.
23. Marsh M., Helenius A. Virus entry into animal cells. Adv. Virus Res. 36:1989;107-151.
24. Matlin K. S., Reggio H., Helenius A., Simons K. Infectious entry pathway of influenza virus in a canine kidney cell line. J. Cell. Biol. 91:1982;601-613.
25. Maxfield F. R. Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J. Cell. Biol. 95:1982;676-681.
26. Miller N., Hutt-Fletcher L. M. Epstein-Barr virus enters B cells and epithelial cells by different routes. J. Virol. 66:1992;3409-3414.
27. Mizzen L., Hilton A., Cheley S., Anderson R. Attenuation of murine coronavirus infection by ammonium chloride. Virology. 142:1985;378-388.
28. Nash T. C., Buchmeier M. J. Spike glycoprotein-mediated fusion in biliary glycoprotein-independent cell-associated spread of mouse hepatitis infection. Virology. 223:1996;68-78.
29. Niemann H., Boschek B., Evans D., Rosing M., Tamura T., Klenk H.-D. Post-translational glycosylation of coronavirus glycoprotein E1: Inhibition by monensin. EMBO J. 12:1982;1499-1504.
30. Ryder E. F., Snyder E. Y., Cepko C. L. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J. Neurobiol. 21:1990;356-375.
31. Scheid A., Choppin P. Protease activation mutants of Sendai virus: Activation of biological properties by specific proteases. Virology. 69:1976;265-277.
32. Stauber R., Pfleiderera M., Siddell S. Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for fusion activity. J. Gen. Virol. 74:1993;183-191.
33. Sturman L. S., Holmes K. V., Behnke J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 33:1980;449-462.
34. Sturman L. S., Ricard C. S., Holmes K. V. Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37°C correlates with virus aggregation and virus-induced cell fusion. J. Virol. 64:1990;3042-3050.
35. Taguchi F. Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2. J. Virol. 73:1993;1195-1202.
36. Van Dinter S., Flintoff W. F. Rat glial cells are defective in murine coronavirus internalization. J. Gen. Virol. 68:1987;1677-1685.
37. Weiland M., Mussgay M., Weiland F. Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma. J. Exp. Med. 148:1978;408-423.
38. Weismiller D. G., Sturman L. S., Buchmeier M. J., Fleming J. O., Holmes K. V. Monoclonal antibodies to the peplomer glycoprotein of coronavirus mouse hepatitis virus identify two subunits and detect a conformational change in the subunit released under mild alkaline conditions. J. Virol. 64:1990;3051-3055.
39. White J. M. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:1990;675-697.
40. Yokomori K., Asanaka M., Stohlman S. A., Lai M. M. C. A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology. 196:1993;45-56.